{"id":1633,"date":"2015-01-18T23:23:48","date_gmt":"2015-01-18T23:23:48","guid":{"rendered":"https:\/\/palladiumcapital.com\/?page_id=1633"},"modified":"2015-02-02T12:19:14","modified_gmt":"2015-02-02T12:19:14","slug":"vbi-vaccines-inc","status":"publish","type":"page","link":"https:\/\/www.palladiumcapital.com\/client-profiles\/vbi-vaccines-inc\/","title":{"rendered":"VBI Vaccines Inc."},"content":{"rendered":"<table>\n<tbody>\n<tr>\n<td colspan=\"4\">\n<table class=\"client-links aligncenter\" align=\"center\">\n<tbody>\n<tr>\n<td><a href=\"http:\/\/www.vbivaccines.com\/\" target=\"_blank\"><img decoding=\"async\" loading=\"lazy\" class=\"alignnone size-full wp-image-1577\" src=\"https:\/\/palladiumcapital.com\/wp-content\/uploads\/2015\/01\/icon-home.gif\" alt=\"icon-home\" width=\"35\" height=\"34\" \/><\/a><\/td>\n<td><a href=\"http:\/\/finance.yahoo.com\/echarts?s=VBIV+Interactive#\" target=\"_blank\"><img decoding=\"async\" loading=\"lazy\" class=\"alignnone size-full wp-image-1576\" src=\"https:\/\/palladiumcapital.com\/wp-content\/uploads\/2015\/01\/icon-chart.gif\" alt=\"icon-chart\" width=\"30\" height=\"34\" \/><\/a><\/td>\n<td><a href=\"http:\/\/finance.yahoo.com\/q?s=VBIV&amp;ql=1\" target=\"_blank\"><img decoding=\"async\" loading=\"lazy\" class=\"alignnone size-full wp-image-1578\" src=\"https:\/\/palladiumcapital.com\/wp-content\/uploads\/2015\/01\/icon-info.gif\" alt=\"icon-info\" width=\"30\" height=\"34\" \/><\/a><\/td>\n<td><a href=\"http:\/\/www.google.com\/search?hl=en&amp;gl=us&amp;tbm=nws&amp;authuser=0&amp;q=Variation+Biotechnologies%2C+Inc.%22&amp;oq=Variation+Biotechnologies%2C+Inc.%22&amp;gs_l=news-cc.3..43j43i53.2844.25786.0.26052.12.4.0.8.0.0.83.285.4.4.0...0.0...1ac.1.X0E6jTBD8f4&amp;gws_rd=ssl\" target=\"_blank\"><img decoding=\"async\" loading=\"lazy\" class=\"alignnone size-full wp-image-1579\" src=\"https:\/\/palladiumcapital.com\/wp-content\/uploads\/2015\/01\/icon-news.gif\" alt=\"icon-news\" width=\"39\" height=\"33\" \/><\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"4\">\n<table class=\"tombstones aligncenter\">\n<tbody>\n<tr>\n<td><a href=\"https:\/\/palladiumcapital.com\/wp-content\/uploads\/2013\/07\/VBIV-Merger.jpg\"><img decoding=\"async\" loading=\"lazy\" class=\"alignnone size-medium wp-image-1440\" src=\"https:\/\/palladiumcapital.com\/wp-content\/uploads\/2013\/07\/VBIV-Merger-263x300.jpg\" alt=\"VBIV Merger\" width=\"263\" height=\"300\" srcset=\"https:\/\/www.palladiumcapital.com\/wp-content\/uploads\/2013\/07\/VBIV-Merger-263x300.jpg 263w, https:\/\/www.palladiumcapital.com\/wp-content\/uploads\/2013\/07\/VBIV-Merger-898x1024.jpg 898w, https:\/\/www.palladiumcapital.com\/wp-content\/uploads\/2013\/07\/VBIV-Merger-624x711.jpg 624w\" sizes=\"(max-width: 263px) 100vw, 263px\" \/><\/a><\/td>\n<td><a href=\"https:\/\/palladiumcapital.com\/wp-content\/uploads\/2013\/07\/VBI-Tombstone-Merger-Side-2.jpg\"><img decoding=\"async\" loading=\"lazy\" class=\"alignnone size-medium wp-image-1441\" src=\"https:\/\/palladiumcapital.com\/wp-content\/uploads\/2013\/07\/VBI-Tombstone-Merger-Side-2-263x300.jpg\" alt=\"VBI Tombstone ( Merger - Side 2)\" width=\"263\" height=\"300\" srcset=\"https:\/\/www.palladiumcapital.com\/wp-content\/uploads\/2013\/07\/VBI-Tombstone-Merger-Side-2-263x300.jpg 263w, https:\/\/www.palladiumcapital.com\/wp-content\/uploads\/2013\/07\/VBI-Tombstone-Merger-Side-2-898x1024.jpg 898w, https:\/\/www.palladiumcapital.com\/wp-content\/uploads\/2013\/07\/VBI-Tombstone-Merger-Side-2-624x711.jpg 624w\" sizes=\"(max-width: 263px) 100vw, 263px\" \/><\/a><\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/palladiumcapital.com\/wp-content\/uploads\/2014\/03\/VBI-Tombstone1.jpg\"><img decoding=\"async\" loading=\"lazy\" class=\"alignnone size-medium wp-image-1401\" src=\"https:\/\/palladiumcapital.com\/wp-content\/uploads\/2014\/03\/VBI-Tombstone1-263x300.jpg\" alt=\"VBI Tombstone\" width=\"263\" height=\"300\" srcset=\"https:\/\/www.palladiumcapital.com\/wp-content\/uploads\/2014\/03\/VBI-Tombstone1-263x300.jpg 263w, https:\/\/www.palladiumcapital.com\/wp-content\/uploads\/2014\/03\/VBI-Tombstone1.jpg 570w\" sizes=\"(max-width: 263px) 100vw, 263px\" \/><\/a><\/td>\n<td><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>VBI Vaccines Inc. (Nasdaq: VBIV) is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI\u2019s eVLP vaccine platform allows for the design of enveloped (\u201ce\u201d) virus-like particle (\u201cVLP\u201d) vaccines that closely mimic the target virus. The company\u2019s lead eVLP asset is a prophylactic Cytomegalovirus (CMV) vaccine; VBI has initiated work for GMP manufacturing of its CMV candidate for use in formal preclinical and Phase I trials. The company\u2019s second platform is a thermostable technology that enables the development of vaccines and biologics that can withstand storage or shipment at constantly fluctuating temperatures. VBI has completed proof of concept thermostability studies on a number of vaccine and biologic targets. VBI is headquartered in Cambridge, MA with research facilities in Ottawa, Canada.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>VBI Vaccines Inc. (Nasdaq: VBIV) is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI\u2019s eVLP vaccine platform allows for the design of enveloped (\u201ce\u201d) virus-like particle (\u201cVLP\u201d) vaccines that closely mimic the target virus. The company\u2019s lead eVLP asset is a prophylactic Cytomegalovirus (CMV) vaccine; VBI [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1574,"parent":22,"menu_order":0,"comment_status":"open","ping_status":"closed","template":"page-templates\/client-profile.php","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/pages\/1633"}],"collection":[{"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/comments?post=1633"}],"version-history":[{"count":0,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/pages\/1633\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/pages\/22"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/media\/1574"}],"wp:attachment":[{"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/media?parent=1633"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}